Kestra Medical Technologies (KMTS) Cash from Operations (2024 - 2026)
Kestra Medical Technologies (KMTS) has disclosed Cash from Operations for 3 consecutive years, with 18366000.0 as the latest value for Q1 2026.
- Quarterly Cash from Operations fell 2.05% to 18366000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 87039000.0 through Jan 2026, down 27.06% year-over-year, with the annual reading at 77608000.0 for FY2025, 7.44% down from the prior year.
- Cash from Operations for Q1 2026 was 18366000.0 at Kestra Medical Technologies, roughly flat from 18343000.0 in the prior quarter.
- The five-year high for Cash from Operations was 14948000.0 in Q2 2024, with the low at 26274000.0 in Q3 2025.
- Average Cash from Operations over 3 years is 19442375.0, with a median of 18199500.0 recorded in 2024.
- Peak annual rise in Cash from Operations hit 1.59% in 2025, while the deepest fall reached 60.93% in 2025.
- Over 3 years, Cash from Operations stood at 18056000.0 in 2024, then decreased by 1.59% to 18343000.0 in 2025, then dropped by 0.13% to 18366000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods came in at 18366000.0, 18343000.0, and 26274000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.